bibliographicCitation |
Cejka D, Kuntner C, Preusser M, Fritzer-Szekeres M, Fueger BJ, Strommer S, Werzowa J, Fuereder T, Wanek T, Zsebedics M, Mueller M, Langer O, Wacheck V. FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo. British Journal of Cancer. 2009 May 12;100(11):1739–45. doi: 10.1038/sj.bjc.6605076. |